<div id="readability-page-1"><p>In a report released today, Rick Wise from Stifel Nicolaus maintained a Hold rating on Treace Medical Concepts, with a price target of <span id="expert-recommendation-target">$5.00</span>.</p><h3>Meet Your ETF AI Analyst</h3><ul><li> Discover how TipRanks' <i>ETF</i> AI Analyst  can help you make smarter investment decisions </li><li>   Explore ETFs TipRanks' users love  and see what insights the <b><i>ETF</i> AI Analyst</b> reveals about the ones you follow.</li></ul> <p>According to TipRanks, Wise is a 3-star analyst with an average return of <span>1.0%</span> and a 50.60% success rate. Wise covers the Healthcare sector, focusing on stocks such as Artivion, Solventum Corporation, and Edwards Lifesciences.</p> <p>In addition to Stifel Nicolaus, Treace Medical Concepts also received a Hold from BTIG’s Ryan Zimmerman in a report issued today. However, on the same day, J.P. Morgan downgraded Treace Medical Concepts (NASDAQ: TMCI) to a Sell.</p></div>

TMCI

<p>Treace Medical Concepts (TMCI) received a Hold rating from Stifel Nicolaus, with a price target of $5.00, as reported by analyst Rick Wise. Wise, a 3-star analyst, has a 50.60% success rate. Additionally, BTIG's Ryan Zimmerman also issued a Hold rating, while J.P. Morgan downgraded TMCI to a Sell on the same day.</p>

Treace Medical Concepts (TMCI) Gets a Hold from Stifel Nicolaus